Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

Sharon Worcester

  • News

    Factor XI inhibitor–based anticoagulation strategies gain ground

    November 18, 2020

    “When we compare the FXI inhibitors with existing anticoagulants, we don’t necessarily want to go up against the DOACs.”

  • News

    Higher death rate seen in cancer patients with nosocomial COVID-19

    July 30, 2020

    All-cause mortality was higher in cancer patients with hospital-acquired COVID-19 than in those with community-acquired COVID-19.

  • 1
    News

    Doctors push back on treating COVID-19 as HAPE

    April 21, 2020

    The pathophysiological mechanism of HAPE is a “fundamentally different phenomenon” than what is seen in COVID-19–related ARDS, experts noted in a recent commentary.

  • 1
    News

    Is protocol-driven COVID-19 respiratory therapy doing more harm than good?

    April 6, 2020

    “This is a kind of disease in which you don’t have to follow the protocol – you have to follow the physiology. Unfortunately, many, many doctors around the world cannot think outside the protocol,” said Dr. Luciano Gattinoni.

  • 1
    News

    Reports increasingly suggest anosmia/hyposmia can signal early COVID-19 infection

    March 24, 2020

    But a WHO expert said the organization needs to look into whether anosmia is an early sign and symptom.

  • 1
    News

    COVID-19 in China: Children have less severe disease, but are vulnerable

    March 19, 2020

    The findings of this case review underscore the possibility that children “may play a major role in community-based viral transmission” of novel coronavirus 2019.

  • 1
    News

    Wuhan case review: COVID-19 characteristics differ in children vs. adults

    March 13, 2020

    “Early chest CT screening and timely follow-up, combined with corresponding pathogen detection, is a feasible clinical protocol in children.”

  • 1
    News

    The 2019 novel coronavirus: Case review IDs clinical characteristics

    February 5, 2020

    A review of coronavirus pneumonia cases in Wuhan, China, suggests older men and those with comormid conditions are most likely to be affected by the 2019-nCoV.

  • 1
    News

    Aspirin plus a DOAC may do more harm than good in some

    December 8, 2019

    Adding aspirin to DOAC therapy for the secondary prevention of VTE or the prevention of stroke associated with NVAF without a clear indication increased bleeding risks in a large cohort.

  • 1
    News

    Large population-based study underscores link between gout, CVD event risk

    November 23, 2019

    ATLANTA – The relationships between gout and fatal and nonfatal CVD events found in a large population-based health data linkage study in New Zealand were not ameliorated by allopurinol use or serum urate lowering to treatment target.

1 2 3Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2000-2023 by the Society of Hospital Medicine and related companies. All rights reserved. ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences